Powered by

Home Profile

Who is Eric Feigl-Ding, raising alarm on new covid wave?

Eric Feigl-Ding, an epidemiologist and health economist, estimates that more than 60 per cent of China and 10 per cent of Earth’s population

By Ground report
New Update
Who is Eric Feigl-Ding, raising alarm on new covid wave?

Eric Feigl-Ding, an epidemiologist and health economist, estimates that more than 60 per cent of China and 10 per cent of the Earth’s population are likely to be infected in the next 90 days with deaths likely to number in the millions.

In a long Twitter thread, Epidemiologist Eric Feigl Ding, from the Harvard Medical School, shared videos of the situation at a hospital in China that cares for covid-19 patients. In the images of the collapsing health system, it is possible to see patients “stacked”, while they depend on mechanical ventilation. Some gurneys with patients are kept on the floor due to a lack of space.

Who is

Eric Liang Feigl-Ding (born March 28, 1983) is an American public health scientist who is currently an epidemiologist and head of the COVID task force at the New England Institute for Complex Systems. Dr. Eric Feigl-Ding (Eric Ding) is an epidemiologist and health economist, Senior Fellow of the Federation of American Scientists in Washington DC, and Chief Health Economist for Microclinic International.

According to the Harvard TC Chan School of Public Health, he was previously a faculty member and researcher at Harvard Medical School and the Harvard T.H. Chan School of Public Health. He is also Chief Health Economist at Microclinic International and Co-Founder of the World Health Network.

In January 2020, he was recognized in the media as one of the first to alert the public to the pandemic risk of COVID-19. (Link opens in a new tab) It is part of FAS's job to stop COVID misinformation and communication with the lay public.

Dr. Feigl-Ding's work focuses on the intersection of public health and public policy. He also currently works on behavioral interventions for prevention, Medicare cost and quality improvement, drug safety, diabetes/obesity prevention, and public health programs in the US.

He has more experience designing and delivering of randomized trials, systematic reviews, public health programs, implementation of public policies and the use of big data to improve health systems.

Communicating sophisticated scientific papers

During the beginning of the pandemic, he emphasized the importance of social media to alert the public and also to keep them informed with the latest developments both nationally and internationally.

He also illustrated how powerful social networks are in communicating sophisticated scientific papers and reports in a more understandable way for the public. Dr. Feigl-Ding concluded the webinar by stating that the precautionary approach is still recommended in light of the latest mutations and vaccination rates around the world.

ALSO READ